摘要 |
<p>1. Technical Result Increase in efficiency of treatment of progesterone-related maladies. 2. Essence The present invention provides compounds wherein R1 and R2 are independent substituents selected from the group of H, optionally substituted C1 to C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3 to C8 cycloalkyl, aryl, heterocyclic groups, or CORA or NRBCOR; or R1 and R2 are fused to form an optionally substituted 3 to 8 membered Spiro cyclic ring or a Spiro cyclic ring containing one to three heteroatoms selected from O, S and N; RA is selected from H, amino, or optionally substituted C1 to C3 alkyl, aryl, C1 to C3 alkoxy, or C1 to C3 aminoalkyl groups; R8 is H, C1 to C3 alkyl, or substituted C1 to C3 alkyl; R3 is H, OH, NH2 or optionally substituted C1 to C6 alkyl, C3 to C6 alkenyl, or alkynyl groups; RC is selected from H or optionally substituted C1 to C3 alkyl, aryl, C1 to C3 alkoxy, or C1 to C3 aminoalkyl groups; Q1 is S, NR7; or CR8R9, R5 is an optionally trisubstituted benzene ring or an optionally substituted five or six membered heterocyclic ring with 1, 2, or 3 ring heteroatoms selected from the group of O, S, SO, SO2 or NR6; or a pharmaceutically acceptable salt thereof, as well as methods of using these compounds for contraception and the treatment of progesterone-related maladies. 3. Field of Application Medicine.</p> |